{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T00:14:06Z","timestamp":1663805646178},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s43441-020-00145-z","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T08:37:10Z","timestamp":1598258230000},"page":"1208-1214","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Reducing Uninformative IND Safety Reports: A List of Serious Adverse Events anticipated to Occur in Patients with Lung Cancer"],"prefix":"10.1007","volume":"54","author":[{"given":"Phil","family":"Bonomi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Stuccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. J.","family":"Delgra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith K.","family":"Chuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Spira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne C.","family":"Deitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gideon M.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghua","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Upal","family":"Basu Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Selig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,26]]},"reference":[{"key":"145_CR1","volume-title":"Safety reporting requirements for INDs (investigational new drug applications) and BA\/BE (bioavailability\/bioequivalence) studies","author":"FDA","year":"2012","unstructured":"FDA. Safety reporting requirements for INDs (investigational new drug applications) and BA\/BE (bioavailability\/bioequivalence) studies. Silver Spring: Administration USFaD; 2012."},{"key":"145_CR2","volume-title":"Safety assessment for IND safety reporting guidance for industry","author":"FDA","year":"2015","unstructured":"FDA. Safety assessment for IND safety reporting guidance for industry. Silver Spring: Administration USFaD; 2015."},{"key":"145_CR3","volume-title":"Final rule: investigational new drug safety reporting requirements for human drug and biological products and safety reporting requirements for bioavailability and bioequivalence studies in humans","author":"FDA","year":"2015","unstructured":"FDA. Final rule: investigational new drug safety reporting requirements for human drug and biological products and safety reporting requirements for bioavailability and bioequivalence studies in humans. Silver Spring: Administration USFaD; 2015."},{"key":"145_CR4","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1158\/1078-0432.CCR-15-2082","volume":"22","author":"JP Jarow","year":"2016","unstructured":"Jarow JP, Casak S, Chuk M, Ehrlich LA, Khozin S. The majority of expedited investigational new drug safety reports are uninformative. Clin Cancer Res. 2016;22:2111\u20133.","journal-title":"Clin Cancer Res"},{"key":"145_CR5","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.2147\/COPD.S83135","volume":"10","author":"DM Kern","year":"2015","unstructured":"Kern DM, Davis J, Williams SA, et al. Validation of an administrative claims-based diagnostic code for pneumonia in a US-based commercially insured COPD population. Int J Chronic Obstr Pulm Dis. 2015;10:1417\u201325.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"key":"145_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1472-6963-11-43","volume":"11","author":"DW Mapel","year":"2011","unstructured":"Mapel DW, Dutro MP, Marton JP, Woodruff K, Make B. Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data. BMC Health Serv Res. 2011;11:43.","journal-title":"BMC Health Serv Res"},{"issue":"Suppl 1","key":"145_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/pds.2341","volume":"21","author":"L Tamariz","year":"2012","unstructured":"Tamariz L, Harkins T, Nair V. A systematic review of validated methods for identifying venous thromboembolism using administrative and claims data. Pharmacoepidemiol Drug Saf. 2012;21(Suppl 1):154\u201362.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"145_CR8","volume-title":"NCI comorbidity index overview","author":"NCI","year":"2019","unstructured":"NCI. NCI comorbidity index overview. Cary: Institute NC; 2019."}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-020-00145-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s43441-020-00145-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-020-00145-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T01:05:18Z","timestamp":1616720718000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s43441-020-00145-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,26]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["145"],"URL":"https:\/\/doi.org\/10.1007\/s43441-020-00145-z","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,26]]},"assertion":[{"value":"28 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}